132 related articles for article (PubMed ID: 38173293)
1. The first evidence of mismatch repair deficiency in mesonephric-like adenocarcinoma of the endometrium: clinicopathological and molecular features of a case emphasising a possible endometrioid carcinogenesis.
Angelico G; Salvatorelli L; Tinnirello G; Santoro A; Zannoni GF; Puzzo L; Magro G
Histopathology; 2024 May; 84(6):1068-1070. PubMed ID: 38173293
[No Abstract] [Full Text] [Related]
2. Pilomatrix-like High-grade Endometrioid Carcinoma is a Morphologically and Immunophenotypically Distinct Entity and May Show Mismatch Repair Deficiency.
Arciuolo D; Travaglino A; Santoro A; Roberti P; Raffone A; Inzani F; Zannoni GF
Int J Gynecol Pathol; 2023 Jan; 42(1):68-69. PubMed ID: 35180769
[No Abstract] [Full Text] [Related]
3. Coexistence of endometrial mesonephric-like adenocarcinoma and endometrioid carcinoma suggests a Müllerian duct lineage: a case report.
Yano M; Shintani D; Katoh T; Hamada M; Ito K; Kozawa E; Hasegawa K; Yasuda M
Diagn Pathol; 2019 Jun; 14(1):54. PubMed ID: 31174566
[TBL] [Abstract][Full Text] [Related]
4. Molecular Modifiers of Hormone Receptor Action: Decreased Androgen Receptor Expression in Mismatch Repair Deficient Endometrial Endometrioid Adenocarcinoma.
Gan Q; Crumley S; Broaddus RR
Int J Gynecol Pathol; 2019 Jan; 38(1):44-51. PubMed ID: 29210800
[TBL] [Abstract][Full Text] [Related]
5. Two Distinct Tumorigenic Processes in Endometrial Endometrioid Adenocarcinoma.
Sugiyama Y; Gotoh O; Fukui N; Tanaka N; Hasumi K; Takazawa Y; Noda T; Mori S
Am J Pathol; 2020 Jan; 190(1):234-251. PubMed ID: 31733184
[TBL] [Abstract][Full Text] [Related]
6. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract][Full Text] [Related]
7. A Combined Morphologic and Molecular Approach to Retrospectively Identify KRAS-Mutated Mesonephric-like Adenocarcinomas of the Endometrium.
Kolin DL; Costigan DC; Dong F; Nucci MR; Howitt BE
Am J Surg Pathol; 2019 Mar; 43(3):389-398. PubMed ID: 30489318
[TBL] [Abstract][Full Text] [Related]
8. An Expanded Series of Pilomatrix-like High-grade Endometrioid Carcinoma (PiMHEC), Including Both MMR Deficient and MMR Proficient Cases.
Xu J; Park KJ; Weisman PS
Int J Gynecol Pathol; 2024 Jan; 43(1):67-69. PubMed ID: 37192144
[No Abstract] [Full Text] [Related]
9. Mesonephric-like Adenocarcinoma of the Uterine Corpus: Comprehensive Analyses of Clinicopathological, Molecular, and Prognostic Characteristics With Retrospective Review of 237 Endometrial Carcinoma Cases.
Kim HG; Kim H; Yeo MK; Won KY; Kim YS; Han GH; Kim HS; Na K
Cancer Genomics Proteomics; 2022; 19(4):526-539. PubMed ID: 35732320
[TBL] [Abstract][Full Text] [Related]
10. Villoglandular adenocarcinoma of the endometrium.
Ambros RA; Malfetano JH
Am J Surg Pathol; 2000 Jan; 24(1):155-6. PubMed ID: 10632501
[No Abstract] [Full Text] [Related]
11. Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.
Travaglino A; Raffone A; Santoro A; Raimondo D; Angelico G; Valente M; Arciuolo D; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Seracchioli R; Zannoni GF
Gynecol Oncol; 2021 Sep; 162(3):804-808. PubMed ID: 34266691
[TBL] [Abstract][Full Text] [Related]
12. Expression of p53 in imprint smears of endometrial carcinoma.
Kosmas K; Stamoulas M; Marouga A; Kavantzas N; Patsouris E; Athanassiadou P
Diagn Cytopathol; 2014 May; 42(5):416-22. PubMed ID: 24167025
[TBL] [Abstract][Full Text] [Related]
13. Endometrioid carcinoma of the endometrium: pathologic and molecular features.
Azueta A; Gatius S; Matias-Guiu X
Semin Diagn Pathol; 2010 Nov; 27(4):226-40. PubMed ID: 21309258
[TBL] [Abstract][Full Text] [Related]
14. Frequent Mismatch Repair Protein Deficiency in Mixed Endometrioid and Clear Cell Carcinoma of the Endometrium.
Köbel M; Tessier-Cloutier B; Leo J; Hoang LN; Gilks CB; Soslow RA; Delair D; Stewart CJR; Lee CH
Int J Gynecol Pathol; 2017 Nov; 36(6):555-561. PubMed ID: 28114191
[TBL] [Abstract][Full Text] [Related]
15. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
[TBL] [Abstract][Full Text] [Related]
17. CD10 and calretinin staining of endocervical glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma.
McCluggage WG; Oliva E; Herrington CS; McBride H; Young RH
Histopathology; 2003 Aug; 43(2):144-50. PubMed ID: 12877729
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of endometrial carcinomas: endometrioid, serous and clear cell adenocarcinomas in association with genetic analysis.
Yasuda M
J Obstet Gynaecol Res; 2014 Dec; 40(12):2167-76. PubMed ID: 25363801
[TBL] [Abstract][Full Text] [Related]
19. Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.
Flannery CA; Saleh FL; Choe GH; Selen DJ; Kodaman PH; Kliman HJ; Wood TL; Taylor HS
J Clin Endocrinol Metab; 2016 Jul; 101(7):2883-91. PubMed ID: 27088794
[TBL] [Abstract][Full Text] [Related]
20. c-Met and RON expression levels in endometrial adenocarcinoma tissue and their relationship with prognosis.
Zhuang XP; Jin WW; Teng XD; Yuan ZZ; Lin QQ; Xu ST
Eur J Gynaecol Oncol; 2015; 36(3):255-9. PubMed ID: 26189249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
